Environmental risk factors cause DNA damages. Imprecise DNA repair leads to chromosome aberrations, genome destabilization and hepatocarcinogenesis. Ku is a key DNA double-strand break repair protein. We hypothesized that the genetic variants in Ku subunits encoding genes, XRCC5/XRCC6, may contribute to hepatocellular carcinoma (HCC) susceptibility. We genotyped 13 common single nucleotide polymorphisms (SNPs) in XRCC5 and XRCC6 and evaluated their associations with HCC risk in 689 pathologically confirmed cases and 690 cancer-free controls from a Chinese population. We found that a significantly reduced risk for HCC was associated with XRCC5 rs16855458 [odds ratio (OR) 5 0.59; 95% confidence interval (CI) 5 0.4320.81; CA 1 AA versus CC] and a significantly increased risk for HCC was associated with XRCC5 rs9288516 (OR 5 2.02; 95% CI 5 1.4222.86; TA 1 AA versus TT) even after Bonferroni correction (P corrected 5 0.026 and 0.002, respectively). The effects of rs16855458 (OR 5 0.57; 95% CI 5 0.3720.86, P 5 0.008) and rs9288516 (OR 5 1.86; 95% CI 5 1.1922.90, P 5 0.007) were more significant in hepatitis B surface antigen-infected subjects than non-infected subjects. The haplotype-based analysis revealed that in XRCC5, AA in block 1 (OR 5 0.63; 95% CI 5 0.4820.83) and CGGTT in block 2 (OR 5 0.52; 95% CI 5 0.3920.69) were associated with decreased HCC risk (P corrected 5 0.013 and <0.001, respectively). The aforementioned two SNPs exhibited a significant cumulative risk effect (P trend < 0.001). Additionally, potential interaction among XRCC5 rs9288516 and rs2267437, rs5751131 in XRCC6 was indicated by the multifactor dimensionality reduction analysis. In conclusion, XRCC5 variants may play a role in determining individual's HCC susceptibility, which warranted validation in larger studies.
Introduction
Despite the feasible early detection by the screening of a-fetoprotein and ultrasound examination, hepatocellular carcinoma (HCC) still poses a substantial burden to the public health (1) . With most cases arise in Asia and Africa, the incidence of HCC continues to increase in Western countries, including the USA (1-5). As the major type of primary liver cancer, HCC is among the five most prevalent malignancies worldwide and ranks the third as a cancer killer due to its high fatality rate (6) . Globally, it is estimated that more than half million deaths were caused by HCC annually (6) . It has been documented that the high lethality may stem from a lack of predictable biomarkers, limited effective therapies and high tumor recurrence (7) . All together, there is a need for a precise definition of the molecular carcinogenic mechanism of this malignancy.
Several risk factors have been identified for HCC development, including chronic infection with hepatitis B virus (HBV) or hepatitis C virus, alcoholism, aflatoxin exposure and non-alcoholic steatohepatitis as the major etiologies (5) . Ongoing inflammation will be induced by these carcinogens with continuous genotoxic stress to hepatocyte DNA, leading to cirrhosis and eventually HCC (5, 7) . Given that only a fraction of exposed individuals actually develop HCC, other relevant factors including predisposing genetic variants remain to be investigated.
Genomic instability is a characteristic feature of HCC and has been proposed to contribute to the malignant transformation from chronic inflammatory status (7, 8) . DNA double-strand break (DSB) constitutes a serious threat to genomic integrity. Inactivation of DSB repair is related to uncontrolled cell growth and increased cancer risk (9, 10) . There has been compelling evidence that defective DSB repair accelerates liver carcinogenesis (11) (12) (13) (14) . It has been demonstrated that dysregulation of Ku, the major component of DSB repair, renders hepatocytes sensitive to DNA damages in the inflammatory environment induced by liver carcinogens, the accumulation of mutations and chromosomal aberrations allows apoptosis and excessive cellular proliferation with enhanced genomic instability which triggers tumorigenesis (11) (12) (13) (14) . A growing body of evidence further supported a relationship between differential Ku expression and HCC (15, 16) .
Ku acts as a heterodimeric DNA-binding complex to swiftly initiate DSB repair process, especially the non-homologous end-joining (NHEJ) pathway. It is consisted of two subunits, Ku70 and Ku86, which are encoded by XRCC6 and XRCC5, respectively. The presence of Ku in normal cell is essential for the maintenance of chromosomal integrity and the viability of cell and organism as NHEJ plays a more predominant role in adult mammalians than the alternative DSB repair mechanism, homologous recombination (17, 18) . In addition, Ku protein binds to protect telomere and disrupted Ku function results in telomere shortening and elevated telomeric fusions (19, 20) . Furthermore, telomere erosion is also fundamental to HCC development (7) . Given its pivotal role in carcinogenesis, it is a key issue to evaluate the impact of the genetic variants in Ku subunits encoding genes, XRCC5 and XRCC6, on cancer predisposition.
Numerous studies have examined the relationship between the risk of developing cancer and the genetic variants of XRCC5 and XRCC6. Most of the previous reports focused on breast cancer (21) (22) (23) , whereas emerging studies investigated associations on a variety of tumors, including glioma, lung, bladder and oral cancers (24) (25) (26) (27) (28) (29) among others. However, to our knowledge, no prior study has investigated the role of XRCC5/XRCC6 in HCC susceptibility, despite the documented importance of Ku in hepatocarcinogenesis. Therefore, we conducted this study to evaluate the associations of allelic variants in XRCC5 and XRCC6 and the risk of developing HCC.
Materials and methods

Study participants
Of HCC patients that were admitted to Eastern Hepatobiliary Surgery Hospital between January, 2003 and December, 2005, a total of 689 patients were recruited as cases in this study. The cases were diagnosed on the base of pathological examination or a-fetoprotein elevation (.400 ng/ml) combined with positive imaging (magnetic resonance imaging, MRI and/or computerized tomography, CT) (30) . Patients with self-reported cancer history and previous radiotherapy and chemotherapy for unknown disease conditions were excluded. Pathological and medical records of all cases participants were reviewed to ascertain the diagnosis of HCC. At the time of enrollment, 631 (91.58%) of the recruited HCC patients were incident cases, and the remaining 58 (8.42%) cases had been diagnosed to have HCC before 2003 and revisited the hospital during the period of the study. The control group, frequency matched by age and sex of cases were randomly selected from a community-based physical examination during the same period of case collection. At the end of recruitment, a total of 690 participants that had neither selfreported history of cancer of any sites nor any history of radiotherapy/chemotherapy for unknown disease conditions were included. The cases and controls were unrelated ethnic Han Chinese resident in Shanghai and its surrounding provinces (Zhejiang, Jiangsu and Anhui) in east China. The Fudan University Ethics Committee for Human Subject Research approved the subject recruitment method and following procedure in the present study. The participation rate was 69% for cases and 78% for controls.
All consenting cases and controls underwent interviews with structured questionnaires, and the blood samples were collected at the same time. The questionnaire was used to solicit demographic data (e.g. age, sex and ethnicity) and lifetime consumption of tobacco smoking and alcohol drinking. The subjects who smoked more than one cigarette per day for .1 year were classified as smokers. Others were defined as non-smokers. Cumulative smoking dose was expressed as 'pack-years' (the average number of packs of cigarettes smoked per day multiplies total number of years of smoking). For alcohol consumption, subjects who drank at least once per week were considered as drinkers of alcohol. They were asked about the frequency and portion size of their consumption of beer, wine and Chinese hard liquor, and the consumption was quantified according to the average ethanol content of beer (5% in volume), wine (12%) and Chinese hard liquor (40%). All the cases and controls were measured serum HBV markers and antibodies to hepatitis C virus. HBV infection was considered if the seropositivity of hepatitis B surface antigen (HBsAg) was detected.
SNP selection and genotyping
The XRCC5 (located at 2q35) gene is $97 kb in length and contains 21 exons. The XRCC6 gene spans 42.8 kb on 22q13.2-q13.31 and contains 12 exons. Genotype data of Han Chinese from the HapMap project (Rel19/Phase II) were used to select tagSNPs for each gene. Setting minor allele frequency (MAF) . 0.05, Haploview (31) was used to screen for tagSNPs. Three tagSNPs were selected for XRCC6 by using an r 2 threshold of 0.8 after forcing Haploview to include two additional single nucleotide polymorphisms (SNPs) (rs2267437 and rs132793) that were reported in literature (22, 23) . In the case of XRCC5 tagSNP selection, because of the extensive haplotype diversity and weak linkage disequilibrium (LD) across the entire gene, an r 2 threshold of 0.6 was used following the suggestions by Carlson et al. (32) due to our financial constraints. As a result, eight tagSNPs of XRCC5 were selected.
Genomic DNA was extracted from whole blood samples using the conventional phenol/chloroform extraction method. Isolated DNA was diluted to 5 ng/ll and distributed into 384-well plates. Genotyping was performed using the Taqman SNP Genotyping Assay (ABI, Foster City, CA) following the manufacturer's instructions. The unlabeled PCR primers and TaqMan minor groove binder probes (FAM and VIC dye-labeled) were designed using the Primer Express Oligo Design software v2.0. The information on the primers/probes sequences and assay conditions are upon request. The genotypes were determined by scanning plates on the ABI PRISM 7900HT Sequence Detection System with end point reading. Eight duplicate samples and eight no-template controls were also included in each plate for quality control, and the genotyping achieved 100% reproducibility.
Statistical analyses
The v 2 test was used to compare the differences in demographic characteristics (age and sex), smoking status, pack-years of smoking, drinking status, alcohol intake per day, HBsAg status and each allele and genotype frequency distribution. Departure from Hardy-Weinberg equilibrium for each polymorphism was assessed by Pearson v 2 test for goodness-of-fit among controls. Unconditional logistic regression was conducted to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for association between each SNP and HCC risk. The ORs were adjusted for age, sex, pack-years, alcohol intake per day and HBsAg status. The reference group is the ancestral allele of each SNP defined in the dbSNP database (http://www.ncbi.nlm.nih.gov/sites/entrez) or the common allele in control if no available ancestral allele data. As the genuine inheritance pattern is unknown, analysis under the codominant model was conducted. In order to improve study power, we also took modes of inheritance into consideration. The Akaike's information criterion was employed to determine the best-fitting genetic model from additive, dominant and recessive models for each SNP. Stratified analysis was performed for age, sex, smoking status, drinking status and infection of HBV. The interactions between the above-mentioned characteristics and SNPs were evaluated by comparing the likelihood of the unconditional logistic regression models with and without an interaction term. Using the median age of controls, we defined young subjects as 50 years and old subjects as .50 years old. All statistical tests were two sided. The Bonferroni correction was applied to ease the issue of multiple testing.
LD between SNPs was examined by Haploview to partition haplotype blocks in each gene using the four gamete rule algorithms. For each SNP pair, the population frequencies of the four possible two-SNP haplotypes (gametes) are computed. If only three gametes are observed with a frequency .0.01 for consecutive markers, it is considered that no recombination occurred and the LD blocks are formed. Haplotype analysis was conducted by Haplo.Stats program (33) . Differences in common haplotypes (frequencies .0.01) distribution were compared between cases and controls using score test. Associations of haplotypes with HCC risk were examined by calculating adjusted ORs and 95% CIs compared with the most common haplotype. Based on the generalized linear model framework in the method, adjustment for confounding variables is allowed. Haplotypes constructed by Haplo.Stats program were validated by PHASE 2.1 (34) .
The cumulative effect of multiple SNPs was also examined by counting the number of adverse genotypes on the basis of the best-fitting genetic model. ORs and their 95% CIs were calculated for the individuals carrying any combination of one, two or more adverse genotypes compared with those carrying none of the adverse genotypes by unconditional logistic regression analysis.
The multifactor dimensionality reduction (MDR) method (http://sourceforge. net/projects/mdr/) was used to further detect gene-gene interactions associated with HCC risk. The MDR approach was described in details and evaluated elsewhere (35, 36) . Using MDR, a new attribute was created by pooling genotypes from multiple SNPs into high-risk and low-risk groups, thereby investigation of interactions were permitted. We used 100-fold cross validation to estimate the prediction error and cross-validation consistency (CVC) of MDR models. The model that minimizes the prediction error and/or has the highest CVC was selected as the best combination of genotypes. The statistical significance of interaction was evaluated using a 1000-fold permutation test. Pack-year and alcohol intake are categorized on the bases of the mean number in controls.
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Results
Subject characteristics
The characteristics of the study participants are presented in Table I . Most of the controls and HCC cases were male. And the average age was 50 years in both groups. There were slightly more males in cases than in controls (87.1% versus 83.2%) and significant difference in age between controls and HCC cases when the subjects were divided into age groups by an interval of 10 years. The cases and controls revealed no statistical difference in smoking status, while there were more heavy smokers in cases (.17 pack-years) than in controls.
Although there was no difference in drinking status between cases and controls, HCC cases were more probably to be heavy drinkers (.14g/day) compared with controls.
Individual SNPs and HCC risk
The observed allele frequencies are summarized in supplementary Table I , available at Carcinogenesis Online with SNP information (dbSNP IDs and locations). All the examined polymorphisms in XRCC5 and XRCC6 were in Hardy-Weinberg equilibrium among the controls. The allele frequencies of two XRCC5 SNPs (rs16855458 and rs9288516) were significantly different between the cases and controls (P 5 0.004 and P , 0.001), and the associations remained significant after Bonferroni correction (P 5 0.049 and P 5 0.001).
The genotypic distributions of XRCC5 and XRCC6 variants between cases and controls are detailed in Table II . Similar significant differences were identified for XRCC5 rs16855458 (P 5 0.016) and XRCC5 rs9288516 (P , 0.001) between HCC cases and controls by examining genotype frequency distributions. As revealed by logistic regression analyses, the variant genotypes of rs16855458 were associated with reduced HCC risk (OR 5 0.59, 95% CI 5 0.43-0.81, P 5 0.001, for CA þ AA compared with CC), and the variant genotypes of rs9288516 were associated with increased HCC risk (OR 5 2.02, 95% CI 5 1.42-2.86, P , 0.001, for TA þ AA compared with TT), after adjustment for age, sex, pack-years of smoking, amount of alcohol intake per day and HBsAg status. These associations remained significant (P 5 0.026 for rs16855458 and P 5 0.002 for rs9288516) after correction for multiple testing.
We further explored the associations of XRCC5 rs16855458 and rs9288516 variant genotypes in stratification analysis. The results were more prominent among the subgroups of young subjects who were ,50 years old (adjusted OR 5 0.50, 95% CI 5 0.34-0.75 for rs16855458, P 50.001 and adjusted OR 5 1.95, 95% CI 5 1.26-3.00 for rs9288516, P 5 0.003), male subjects (adjusted OR 5 0.57, 95% CI 5 0.40-0.79 for rs16855458, P 50.001 and adjusted OR 5 1.87, 95% CI 5 1.29-2.70 for rs9288516, P 50.001), non-smokers (adjusted OR 5 0.57, 95% CI 5 0.36-0.91 for rs16855458, P 5 0.018 and adjusted OR 5 2.21, 95% CI 5 1.30-3.74 for rs9288516, P 5 0.003), non-drinkers (adjusted OR 5 0.60, 95% CI 5 0.39-0.95, for rs16855458, P 5 0.028 and adjusted OR 5 2.51, 95% CI 5 1.52-4.16 for rs9288516, P , 0.001) and HBsAg-positive subjects (adjusted OR 5 0.57, 95% CI 5 0.37-0.86 for rs16855458, P 5 0.008 and adjusted OR 5 1.86, 95% CI 5 1.19-2.90 for rs9288516, P 5 0.007), compared with subjects who were .50 years old, female subjects, Order of SNPs in XRCC6 is rs132770, rs5751131, rs132771 and rs132793.
Genetic polymorphisms in DNA double-strand break repair genes and risk of HCC smokers, drinkers and HBsAg-negative subjects (Table III) , although tests for interaction were not statistically significant.
Haplotypes and HCC risk
Based on the LD pattern between SNPs, two haplotype blocks were identified in XRCC5. Block 1 was composed of rs828704 and rs16855458. Block 2 contained five SNPs from rs668844 to rs1051677. Strong LD was present among four XRCC6 SNPs and therefore formed one haplotype block except for rs2267437, as shown in supplementary Figure 1 , available at Carcinogenesis Online. The associations between haplotype frequencies and HCC risk are summarized in Table IV . For XRCC5, the overall distributions of haplotypes were significantly different between cases and controls in both block 1 and block 2 (P value for global score test was 0.043 and 0.004, respectively). Compared with the most common haplotype AC in block 1, the haplotype AA showed a significant protective effect (adjusted OR 5 0.63, 95% CI 5 0.48-0.83, P 5 0.001) on HCC risk, which contained the potential protective allele of rs16855458. In block 2, the haplotype CGGTT, without the risk-conferring allele of rs9288516, also showed a significant reduction of HCC risk (adjusted OR 5 0.52, 95% CI 50.39-0.69, P , 0.001) compared with the most frequent haplotype CGGAT. The significance remained for the two associations of the haplotype AA in block 1 and the haplotype CGGTT in block 2 after the Bonferroni correction for multiple testing (P 5 0.013 and P , 0.001). Furthermore, the XRCC6 haplotypes were not associated with the risk of HCC.
Combined effect of multiple SNPs
We combined the adverse genotypes of XRCC5 rs16855458 and rs9288516 in each individual to examine possible cumulative risk effect. As shown in Table V , all the individuals were categorized into groups carrying a range of 0-2 adverse genotypes based on the bestfitting model. We observed that the risk of HCC increased progressively with an increasing number of adverse genotypes (P trend , 0.001). The risk-enhancing trend was consistently observed in subgroups (young subjects, old subjects, males, non-smokers, nondrinkers, drinkers, HBsAg negative subjects and HBsAg positive subjects, supplementary Table II is available at Carcinogenesis Online).
To evaluate the combined effect of all the examined loci on HCC risk, we summed the potential adverse genotypes suggested in single-locus analyses of these 13 SNPs for each individual. Likewise, a significant cumulative effect on HCC risk was observed when trend test was performed (P trend , 0.001, supplementary Table III , available at Carcinogenesis Online).
Gene-gene interaction
Furthermore, we used the MDR approach to detect interaction amongst all the SNPs of XRCC5 and XRCC6. The best interaction models of the possible (one-to-four way) SNP combinations are summarized in Table  VI . The best single factor to predict HCC risk was XRCC5 rs9288516 (prediction error , 47%; CVC 555%; P 5 0.057). Both the two-locus (XRCC6 rs2267437 and rs5751131) and three-locus (XRCC5 rs9288516, XRCC6 rs2267437 and rs5751131) models had a prediction error , 45% and showed statistical significance by permutation testing. However, the three-locus model appeared to be the best model for HCC risk prediction with a perfect CVC (100%).
Discussion
In this study, we investigated the contribution of 13 SNPs in XRCC5 and XRCC6 to HCC susceptibility. Two genetic variants in XRCC5, rs16855458 and rs9288516, were identified to be significantly associated with HCC risk, especially among the HBsAg-positive subjects. The associations were further confirmed by the haplotype analysis of XRCC5, in which AA in block 1 and CGGTT in block 2, without the adverse alleles, were associated with decreased HCC risk compared with the most common haplotypes. These associations on overall HCC risk were still noted even after Bonferroni correction for multiple comparisons. Moreover, we found a significant dosage effect for increasing risk of HCC when combined adverse genotypes of rs16855458 and rs9288516 together. Although no effects were detected for XRCC6 polymorphisms individually, interactions between XRCC5 and XRCC6, which encode Ku subunits, were suggested based on MDR analysis. Our findings, for the first time, suggested that SNPs in XRCC5 and XRCC6 may play a role in determination of individual susceptibility profile to HCC. However, a more convincing conclusion can only be reached by further independent replication of the results reported in this investigation. Ku86, the 86 kDa subunit of Ku encoded by human XRCC5, is a critical factor in NHEJ. It binds at the DSB site with Ku70, serving as a hub to recruit the nuclease, the polymerases and the ligase complex. Although forming a heterodimer, Ku86 and Ku70 have unique and independent functions (37) . Ku86 may function outside the Ku heterodimer to influence DNA damage repair for situations when Ku70 is unilaterally degraded or sequestered (38) . This reconcile with our results that the major findings in the present study were from XRCC5. On the other hand, besides the effect on HCC formation shown from Ku86-deficient model noted in the introduction, it is also reported recently that Xrcc5 expression was significantly increased in hepatocarcinogen treated mice to prevent liver tumor induced by DNA damage (39) . Additionally, it is suggested that Ku86 protects liver against oxidative stress (40) , which is associated with inflammation and oncogenic mutations. Moreover, being a multifunctional protein, Ku86 may contribute to liver tumorigenesis through other biological activities. For instance, Ku86 exists as the transcription factor of HCC-related genes. It binds to the promoter and regulates GRP78 gene (41), which is involved in the development of HCC (42, 43) . XRCC5 has evolved into a vital gene for human life, therefore, even a single patient with a mutation in XRCC5 cannot be found (44, 45) , indicating that genetic variations in non-coding regions may be the underlying basis of differing levels of gene transcription and translation. In this study, we found that the variants of two intronic SNPs rs16855458 and rs9288516 had an impact on HCC risk. Although little is known about the functional aspects of this two associated SNPs, it is suggested that these findings are biological plausible. Using the software FASTSNP, rs16855458 and rs9288516 were predicted to cause changes of potential binding sites of transcription factors (46) , which may result in instability of XRCC5 messenger RNA transcript or dysfunction of XRCC5 expression, and finally in tumorigenesis. Additional work to characterize the functions of these two intronic SNPs is warranted. Nevertheless, until that is done we cannot rule out the possibility that the observed modified risks conferred by the variants are truly due to the real casual SNP correlated to them. It is important to note that a similar risk effect was also detected on rs9288516 in a previous study of glioma (24) . In addition, a significant association between the SNP rs3770494 in XRCC5 intron 16, where rs9288516 locates, and lung cancer was shown in a recent report (25) . Intriguingly, this report supported the associations between lung cancer risk and SNPs in the intron 16 region of XRCC5 suggested in our earlier study (data not published). These consistent results indicate that our findings on HCC risk are unlikely to be false positives and other SNPs in proximity merit further investigation for the purpose of fine mapping.
Regarded as another outstanding candidate gene for association with cancer risk, numerous SNPs of XRCC6 have been interrogated by multiple research groups. Their findings are not congruent due to different SNP selection; however, rs2267437 in 5#-flanking region of XRCC6 is the most frequently targeted variation. It was significantly associated with a reduction of breast cancer risk in a Taiwanese population (22) , whereas another study in a Belgian population found a marginally significant protect effect of this SNP on breast cancer (47) . These conflicting results may be due to population heterogeneity of these two studied ethnic groups. The MAF of rs2267437 was much lower in control group of Taiwanese (MAF 5 0.172) than that in Belgian (MAF 5 0.395). In contrast, two other studies failed to identify significant associations with rs2267437 and risk of oral (29) and lung cancer (27) , which were in agreement with our findings on HCC risk. However, rs2267437 was suggested to interact with XRCC6 rs5751131 and XRCC5 rs9288516 in our population, which needs further validation.
Chronic HBV infection, alcohol and smoking cause DNA damage to cellular genome; therefore, we stratified our data for these factors and analyzed the modifying effect of the two significant XRCC5 SNPs to HCC risk in subgroups. The associations of rs16855458 and rs9288516 were more significant in HBsAg-positive subjects, non-smokers and non-drinkers. The sample size reduction in stratification analysis may result in insufficient power to detect significant associations in subpopulations. Furthermore, given that single SNP exhibited modest effect on HCC risk, the strong exposure of smoking and drinking may overpower the contribution of genetic variation to HCC susceptibility. In contrast, HBV infection is a more prominent risk factor of HCC than smoking and drinking in Chinese population. It can induce hepatocarcinogenesis through integrating into host chromosomes. The majority of HCCs developed in chronic HBV carriers contain integrated HBV sequences (48, 49) . Several genes involved in the cell signaling and growth control were identified to be recurrently targets of HBV insertion, the rearrangements and microdeletions at these sites may play a role in HCC development (50) . It has been suggested that viral integration may occur by NHEJ at DSBs in host DNA (51) . A recent study demonstrated that the imprecise NHEJ results in more frequently insertion of viral fragments (52) . The significance of XRCC5 SNPs in HBV-infected subjects heightened the importance of NHEJ pathway in determining the susceptibility to HCC from the early stage of chronic infection. Prospective study is warranted to define its role in different stages of liver carcinogenesis.
The MDR analysis we conducted seemed to support the major finding of rs9288516 because it was identified to be the best single factor to discriminate between cases and controls and involved in the best-fitted three-factor model. The other two SNPs XRCC6 rs2267437 and rs5751131 in the three-locus model were not associated with HCC risk in the single-locus analysis, indicating that their contribution to the development of HCC may depend on the status of the associated SNP in XRCC5. However, the optimal MDR model was constructed only with the selected SNPs in Ku subunits encoding genes. An exhaustive collection of all common SNPs in DSB-related genes would provide more in-depth insights to the complex nature of gene-gene interaction in this pathway. Due to the limited sample size in subgroups and the post hoc data-mining approach, the MDR results need to be interpreted with caution.
In spite of the strong and consistent associations of SNPs in XRCC5 with HCC risk, we recognize several limitations in our study and should be noted. First is the inclusion of non-incident cases, which might introduce a bias. However, exclusion of these cases from the analyses did not have a noticeable impact on the results, albeit the interaction among XRCC5 and XRCC6 SNPs tended to be marginally significant, suggesting that this kind of bias is unlikely to be of significance in this report. Another potential limitation is that there is slight difference in the distribution of sex between cases and controls, although we designed to recruit controls frequency matched to cases by age and gender. Given that the frequency matching was inadequate, several approaches were taken to control for false-positive findings. We adjusted for sex in logistic regression analysis and performed stratification analysis to confirm the association findings. Under these circumstances, the frequency of false-positive findings would be substantially decreased. Future study with larger sample size in independent population is necessary to validate our results.
In summary, our findings in this case-control study indicated that some representative tagSNPs of XRCC5 may modulate the risk of developing HCC. In particular, the associations were more significant in HBV-infected subjects than non-infected subjects. In light of our results, more epidemiologic and functional studies are warranted to elucidate the role of these genetic variants in different stages of hepatocarcinogenesis.
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